Why the study?
Does cardiopulmonary support compared to intraaortic balloon pump improve acute outcomes in high-risk patients undergoing percutaneous transluminal coronary angioplasty?
Does cardiopulmonary support compared to intraaortic balloon pump improve acute outcomes in high-risk patients undergoing percutaneous transluminal coronary angioplasty?
In high-risk patients undergoing PTCA, cardiopulmonary support allows for higher procedural success rates compared to IABP, but at the cost of increased peripheral vascular complications and without a difference in major acute cardiac events.
No takes yet. Share an insight, caveat, or question.
CPS may support higher procedural success in high-risk PTCA despite more complications; hypothesis-generating and should not yet change practice.
Schreiber et al. (1998) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: